Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histopathological characteristics of PRRS and expression profiles of viral receptors in the piglet immune system. | Front Vet Sci | 2024 | 39568484 | PubTator, text mining | PubMed |
| Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach. | NPJ Vaccines | 2024 | 39551795 | PubTator, text mining | PubMed |
| FATS inhibits the Wnt pathway and induces apoptosis through degradation of MYH9 and enhances sensitivity to paclitaxel in breast cancer. | Cell Death Dis | 2024 | 39550407 | PubTator, text mining | PubMed |
| Palmatine attenuates MYH9 mediated nuclear localization of AURKA to induce G2/M phase arrest in colorectal cancer cells. | Int Immunopharmacol | 2024 | 39536490 | PubTator, text mining | PubMed |
| Rosiglitazone-induced white adipocyte browning is regulated by actin and Myh9. | Life Sci | 2024 | 39510170 | PubTator, text mining | PubMed |
| Macrothrombocytopenia and granulopoieitic Döhle body-like inclusions in a MYH9-related disorder. | J Hematop | 2024 | 39508997 | PubTator, text mining | PubMed |
| Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer. | Adv Sci (Weinh) | 2024 | 39488790 | PubTator, text mining | PubMed |
| CircSP3 encodes SP3-461aa to promote ccRCC progression via stabilizing MYH9 and activating the PI3K-Akt signaling pathway. | J Cancer | 2024 | 39440063 | PubTator, text mining | PubMed |
| Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma. | Cell Death Dis | 2024 | 39433745 | PubTator, text mining | PubMed |
| Mechanism of PRRSV infection and antiviral role of polyphenols. | Virulence | 2024 | 39432383 | PubTator, text mining | PubMed |
| Classification and functional analysis of disulfidptosis-associated genes in sepsis. | J Cell Mol Med | 2024 | 39400961 | PubTator, text mining | PubMed |
| Corrigendum: Nonmuscle myosin heavy chain IIA-mediated exosome release via regulation of the rho-associated kinase 1/myosin light chains/actin pathway. | Front Pharmacol | 2024 | 39372208 | PubTator, text mining | PubMed |
| Proteomic insights into early-stage Alzheimer's disease: Identifying key neuronal proteins impacted by amyloid beta oligomers in an in vitro model. | Neuroscience | 2024 | 39362622 | PubTator, text mining | PubMed |
| Study on the expression and prognostic relationship of MYL6B in liver cancer based on bioinformatics. | World J Clin Oncol | 2024 | 39351463 | PubTator, text mining | PubMed |
| Proteome of plasma extracellular vesicles as a source of colorectal cancer biomarkers. | Biomed Khim | 2024 | 39324200 | PubTator, text mining | PubMed |
| Unraveling MYH9-related disease: A case study on misdiagnosis with idiopathic thrombocytopenic purpura, confirmed through genetic. | Heliyon | 2024 | 39309903 | PubTator, text mining | PubMed |
| MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches. | Res Pract Thromb Haemost | 2024 | 39309229 | PubTator, text mining | PubMed |
| The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. | Signal Transduct Target Ther | 2024 | 39300073 | PubTator, text mining | PubMed |
| Combined single cell and spatial transcriptome analysis reveals hedgehog pathway-related genes as potential therapeutic targets for cervical cancer. | Cancer Treat Res Commun | 2024 | 39293140 | PubTator, text mining | PubMed |
| Non-Muscle Myosin II A: Friend or Foe in Cancer? | Int J Mol Sci | 2024 | 39273383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=12